Birmingham researchers to make MGUS monitoring more efficient
News
First treatment for common bladder cancer recommended by NICE
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease
NHS launches spring COVID-19 booster campaign
An estimated 7.5 million people will be invited to receive the booster
SkyCell and Microsoft partner to improve pharma supply chains
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making
MHRA approves prostate cancer imaging agent trofolastat
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK
Endlyz Therapeutics emerges with pipeline for Parkinson’s disease
Research targets lysosomal function restoration for neurodegeneration
SMC approves bimekizumab for hidradenitis suppurativa treatment
The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe...
European Commission approves ustekinumab for paediatric Crohn’s disease
Approval extends ustekinumab’s use to younger patients
Elekta and Azra AI partner to advance cancer registry operations with AI
Collaboration introduces automation to enhance efficiency
4basebio receives MHRA licence for synthetic DNA manufacture
GMP certification enables 4basebio to supply DNA for clinical trials
NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma
Advancing care for stage 3 or 4 Hodgkin lymphoma patients
Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK
Collaboration expands AI-based risk profiling tools
Genome editing offers hope for genetic hearing loss
New therapy developed to repair GJB2 R75W mutation
Amivantamab plus lazertinib shows survival benefit in lung cancer
Janssen drug combination extends life expectancy during trial
